Social Media Ideas for Cgocx

GPOPlus+ (OTCQB:GPOX) Launches GPOX Pulse to Give Investors Direct Access to Company News, SEC Filings and Weekly Busine...

Subscribe today to receive Issue 01 | The America 250 Inaugural Issue. Shareholders and investors can now sign up for free email, SMS alerts and browser notifications at GPOPlus.co...

Invesco Gold & Special Minerals Fund Q1 2026 Commentary

Columbia Small Cap Growth Fund Q1 2026 Commentary

CG Oncology, Inc. (CGON) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Goldman Sachs Large Cap Growth Insights Fund Q1 2026 Commentary

GPOPlus+ (OTCQB:GPOX) Launches OTP Program, Targeting the Fastest-Growing and Most Compliance-Critical Category in Conve...

Building on three years of weekly DSD service across 9 states and more than 70,000 store visits, GPOPlus+ introduces a turnkey OTP program purpose-built for gas stations and conven...

GPOPlus+ (OTCQB:GPOX) Releases Retail Investor Memo Highlighting Proven DSD Model, 6x Revenue Growth, and Scalable Path...

New Retail Investor Edition provides a clear, plain-language overview of a model built for an underserved $50B+ segment and reflects a more direct approach to investor communicatio...

Contango Silver & Gold Inc. (CTGO) Discusses Project Updates and Market Backdrop for Precious Metals Transcript

GPIX: Covered Call ETF On S&P 500 Among Top Performers And The Difference

GPOPlus+ (OTCQB:GPOX) Sponsors FreedomFest 2026, July 8-11 in Las Vegas

GPOX to exhibit at Booth 909 as thousands of investors, entrepreneurs, and thought leaders gather at Caesars Forum; Chairman and CEO Brett H. Pojunis to serve as a judge in the Pri...

Form 4 Ocular Therapeutix Inc For: 12 June

Form 13G CION Ares Diversified Credit Fund For: 3 June

Comstock Capital Value Fund Q1 2026 Commentary

Golconda Gold: Continuing To Create Shareholder Value

Nomura Large Cap Growth Fund Q1 2026 Commentary

Invesco Limited Term California Municipal Fund Q1 2026 Commentary

Buy this cannabis stock for a double, analyst says

Haywood analyst Neal Gilmer maintained a “Buy” rating and $3.25 target on Organigram Holdings (Organigram Global Stock Quote, Chart, News, Analysts, Financials  TSX:OGI) in a May 1...

Oxford Lane Capital Corporation (OXLC) Q4 2026 Earnings Call Transcript

Goldman Sachs Large Cap Value Insights Fund Q1 2026 Commentary

First Eagle Overseas Fund Q1 2026 Commentary

Columbia Contrarian Core Fund Q1 2026 Commentary

Cogent Biosciences: A Pre-Commercial Biotech With Commercial-Stage Leverage

Form 4 Oncotelic Therapeutics Inc For: 17 June

Gold Royalty Corp. (GROY) Analyst/Investor Day - Slideshow